High-density lipoprotein: a new target in the battle against atherothrombotic disease
Hansen, P.R.
Ugeskrift for Laeger 168(5): 468-470
2006
ISSN/ISBN: 1603-6824 PMID: 16472435 Document Number: 9093
A low level of high-density lipoprotein (HDL) cholesterol is an important cardiovascular risk factor. The protective effects of HDL have been attributed to its promotion of reverse cholesterol transport, antioxidant activity and anti-inflammatory actions on endothelial cells. Several treatment strategies aimed at exploiting the favourable effects of HDL are currently undergoing clinical trials and hold considerable promise as a novel approach to atheroprotection.
Document emailed within 1 workday
Related Documents
Matsuda, Y. 1993: High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation Kobe Journal of Medical Sciences 39(1): 1-14Oida, K.; Nakai, T.; Tamai, T.; Kutsumi, Y.; Kobayashi, T.; Hayashi, T.; Yamada, S.; Takeda, R. 1982: Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia Artery 10(4): 266-285
Li, Z.; Tao, Y.; Huang, J.; Wang, Q.; Zhang, D.-h.; Wu, X.-y. 2013: The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction Zhonghua Yi Xue Za Zhi 93(19): 1458-1462
Stevermer, J.J.; Meadows, S.E. 2002: Clinical inquiries. what is the target for low-density lipoprotein cholesterol in patients with heart disease? Journal of Family Practice 51(10): 893
Nimkuntod, P.; Tongdee, P. 2015: Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis Journal of the Medical Association of Thailand 98(Suppl 4): S58-S63
Sathavarodom, N.; Boonyavarakul, A. 2010: Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol Journal of the Medical Association of Thailand 93(Suppl 6): S166-S172
Howard, G.C.; Pizzo, S.V. 1993: Lipoprotein(a) and its role in atherothrombotic disease Laboratory Investigation; a Journal of Technical Methods and Pathology 69(4): 373-386
Campione, K.M. 1981: High density lipoprotein and coronary artery disease Occupational Health and Safety 50(5): 25-30
Akaike, M.; Kikuchi, K.; Aramaki, T.; Okumura, H. 1985: High-density lipoprotein phospholipid concentrations in serum of patients with liver disease Clinical Chemistry 31(6): 1083-1084
Athyros, V.G.; Mikhailidis, D.P.; Papageorgiou, A.A.; Mercouris, B.R.; Athyrou, V.V.; Symeonidis, A.N.; Basayannis, E.O.; Demitriadis, D.S.; Kontopoulos, A.G. 2002: Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study Current medical research and opinion 18(8): 499-502
Gevers Leuven, J.A. 1978: Cholesterol in high density lipoprotein as an anti-risk factor for ischemic heart disease Nederlands Tijdschrift voor Geneeskunde 122(25): 900-904
Adebonojo, S.A.; Ogunnaike, H.O. 1989: High density lipoprotein cholesterol as a determinant factor in coronary heart disease in Africans Journal of the National Medical Association 81(5): 547-556
De Smedt, M.; Van Ginderdeuren, R.; De Vos, R.; Mertens, A.; Muls, E.; Foets, B. 2001: Corneal opacifications in a low high density lipoprotein syndrome: suspicion of fish eye disease: a case report Bulletin de la Societe Belge d'Ophtalmologie 2001(282): 25-30
Bodnar, P.N.; Donish, R.M.; Panasiukova, O.R. 1984: Significance of high-density lipoprotein cholesterol in the development of ischemic heart disease in diabetes mellitus patients Problemy Endokrinologii 30(3): 19-24
Rizzo, M.; Berneis, K.; Zeljkovic, A.; Vekic, J. 2009: Should We Routinely Measure Low-Density and High-Density Lipoprotein Subclasses? Clinical Laboratory 55(11-12): 421-429
SoRelle, R. 2002: ATP III calls for more intensive low-density lipoprotein lowering in target groups Circulation 106(25): E9068
Tilly-Kiesi, M.; Tikkanen, M.J. 1992: Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia Journal of Laboratory and Clinical Medicine 120(1): 103-110
Li, Z.X. 1982: Serum high density lipoprotein cholesterol (HDL-C) level and its regulating factors in healthy subjects and patients with coronary heart disease Zhonghua Yi Xue Za Zhi 62(1): 13-17
Masquelier, M.; Vitols, S.; Peterson, C. 1986: Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice Cancer Research 46(8): 3842-3847
Shikishima, Y.; Kawano, Y.; Shirai, H.; Matsuura, N.; Noma, T. 2001: Inverse correlation between macrophage-colony stimulating factor, cholesterol and high density lipoprotein cholesterol in Kawasaki disease Asian Pacific Journal of Allergy and Immunology 19(2): 85-91